Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

CUSIP: 702712100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
3,182,163
Total 13F shares
37,376,459
Share change
-551,903
Total reported value
$51,570,790
Price per share
$1.38
Number of holders
64
Value change
-$593,641
Number of buys
11
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q4 2022

As of 31 Dec 2022, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,376,459 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Versant Venture Management, LLC, Frazier Life Sciences Management, L.P., Lynx1 Capital Management LP, New Leaf Venture Partners, L.L.C., VANGUARD GROUP INC, Erste Asset Management GmbH, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and Rubric Capital Management LP. This page lists 64 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.